Evolent Health, Inc. - Class A Shares Earnings

Evolent Health, Inc. - Class A Shares’s revenue fell -31.34% since last year same period to $444.33Mn in the Q2 2025. On a quarterly growth basis, Evolent Health, Inc. - Class A Shares has generated -8.13% fall in its revenue since last 3-months.

Evolent Health, Inc. - Class A Shares’s net profit fell -3301.13% since last year same period to $-51.09Mn in the Q2 2025. On a quarterly growth basis, Evolent Health, Inc. - Class A Shares has generated 20.94% jump in its net profits since last 3-months.

Evolent Health, Inc. - Class A Shares’s net profit margin fell -4762.31% since last year same period to -11.5% in the Q2 2025. On a quarterly growth basis, Evolent Health, Inc. - Class A Shares has generated 13.94% jump in its net profit margins since last 3-months.

Evolent Health, Inc. - Class A Shares’s earning per share (EPS) estimates for the current quarter stand at 0.11 - a 37.5% jump from last quarter’s estimates.

Evolent Health, Inc. - Class A Shares’s earning per share (EPS) estimates for the current year stand at 0.11.

Evolent Health, Inc. - Class A Shares’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Evolent Health, Inc. - Class A Shares has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.